773881003: Antiparkinson therapeutic role (role)

SNOMED CT Concept\Qualifier value\Role\Therapeutic role (role)\Antiparkinson therapeutic role

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3726863016 Antiparkinson therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3726864010 Antiparkinson therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4221351000052118 behandlingsfunktion mot Parkinsons sjukdom sv Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Antiparkinson therapeutic role	Is a	Therapeutic role (role)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Selegiline only product in oromucosal dose form	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Carbidopa- and levodopa-containing product in oromucosal dose form	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing istradefylline (medicinal product)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing only istradefylline (medicinal product)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing istradefylline in oral dose form (medicinal product form)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing only istradefylline in oral dose form (medicinal product form)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Opicapone 50 mg oral capsule	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely opicapone 25 milligram/1 each conventional release oral capsule (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely bromocriptine (as bromocriptine mesilate) 800 microgram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Rasagiline (as rasagiline tartrate) 1 mg oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely rasagiline (as rasagiline mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely rasagiline (as rasagiline mesilate) 500 microgram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Biperiden hydrochloride 4 mg prolonged-release oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Pramipexole (as pramipexole dihydrochloride) 520 microgram prolonged-release oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Piribedil-containing product in oral dose form	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Piribedil 50 mg prolonged-release oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Piribedil-containing product	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Piribedil only product	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing only piribedil in oral dose form (medicinal product form)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 350 microgram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 520 microgram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Pramipexole (as pramipexole dihydrochloride) 1.57 mg prolonged-release oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Pramipexole (as pramipexole dihydrochloride) 2.62 mg prolonged-release oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely biperiden lactate 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Product containing precisely ropinirole (as ropinirole hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Ropinirole (as ropinirole hydrochloride) 500 microgram oral tablet	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Rotigotine 125 microgram/hour prolonged-release transdermal patch	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch	Plays role	True	Antiparkinson therapeutic role	Inferred relationship	Some

Start Previous Page 3 of 3

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3726863016	Antiparkinson therapeutic role	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3726864010	Antiparkinson therapeutic role (role)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4221351000052118	behandlingsfunktion mot Parkinsons sjukdom	sv	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)